0
0%
(0)
Prev Close
0
Open
0
Best Bid Price
0
Best Bid Volume
0
Best Ask Price
0
Best Ask Volume
0
 

Performance

Turnover
-
Volume (No of shares)
-
High
-
Low
-
Last Trade Price
-
Last Trade Volume
-
No of Trades
-
Close
-
-
Equity Profile Established In: FEB 14, 1996
Authorized Capital
11,000,000
Issued Shares
99,762,054
Paid up capital
9,976,205
Par Value/Share
0.100
 

Financial Reports

Quarter/ Date/ Description Report Type
Q1 | APR 23, 2018
Un audited Financial statement for period ended 31.03.2018
Yearly | FEB 01, 2018
Financial Statement for the year ended 31- December -2017
Q3 | OCT 30, 2017
Unaudited Interim financial statement for nine months period ended 30 Sep-2017
Q2 | JUL 27, 2017
Unaudited Interim Financial Statements for the six Months period 30th june-2017
Q1 | APR 30, 2017
Unaudited Interim Financial Statements for the Three Months period 31 march-2017
 

FOREIGN INVESTMENTS

Omani 100.00%
Non Omani 100%
GCC
0.00%
Arab
0.00%
Foreigner
0.00%
Total 200%
     

Dividends

Year Cash Bonus Share Cut off Date
20185.00%0.00%FEB 22, 2018
201710.00%0.00%FEB 22, 2017
201610.00%0.00%FEB 24, 2016
201516.00%0.00%MAR 03, 2015
201416.00%0.00%MAR 11, 2014

Profile

Activity
Manufacture pharmaceutical products
Board Information
Chairman
Dr. Ghazi Omar Al Zubaidi
Deputy
Mr khalid bin ali al yahmadi
Secretary
Head of Accounts
Members
Ms Amal Bahwan Dr Waleed Khalid Al Zadjali Mr Rahul Kar Ph Ali Ahmed al Rawahi Mr Vivek Varadan